Topiramate
Product Images NDC 52959-643

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 52959-643). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topiramate-fig01 (Topiramate Fig01)

A line graph showing cumulative rates of time to first seizure over 500 days for Topiramate at 50 mg/day and 400 mg/day doses. The 400 mg/day group has a consistently higher cumulative rate compared to the 50 mg/day group. A p-value of 0.0002 is indicated, suggesting statistical significance.*

FDA Label Image

Topiramate-label-100mg (Topiramate Label 100mg)

Label for TOPIRAMATE 100mg tablet by H.J. Harkins Company, Inc. Includes lot number TPT000C, manufactured by CARACO in Mumbai, India, with expiration 01/12. Compares to Topamax with Mfg. NDC 62756-711-86. The tablet is yellow and round. Label includes federal caution and usage instructions.*

FDA Label Image

Topiramate-structure (Topiramate Structure)

Chemical structure diagram of Topiramate showing its molecular composition with sulfonamide and cyclic ether groups depicted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.